LDTs in oncology are used to detect cancer markers, guide treatment decisions, and monitor patient responses to treatment. These tests can analyze tumor tissues, blood, or other body fluids to look for genetic mutations or other markers associated with specific types of cancer.
With a deep understanding of the intricate landscape of oncology diagnostics, we offer a complete spectrum of services encompassing test design, meticulous validation, regulatory compliance, seamless test launch, and strategic test marketing. By partnering with us, CLIA labs can not only provide their patients with cutting-edge cancer detection solutions but also position themselves at the forefront of medical innovation.
